| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.7M | +2126.3% |
| SG&A Expense | $7.4M | +262.3% |
| Operating Income | -$13.0M | -470.3% |
| Pre-tax Income | -$13.0M | -192.7% |
| Income Tax | $0 | — |
| Net Income | -$13.0M | -192.7% |
| EPS (Basic) | -$1.59 | -54.4% |
| EPS (Diluted) | -$1.59 | -54.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | -72.8% |
| Total Assets | $4.0M | -71.1% |
| Total Liabilities | $1.7M | +183.2% |
| Stockholders' Equity | $2.4M | -82.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.9M | -208.0% |
| Financing Cash Flow | $350K | -97.9% |